Drug Profile


Alternative Names: Ibuprofen; X 0002

Latest Information Update: 08 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Techfields Pharma
  • Class Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Fever; Osteoarthritis; Prostatitis; Spinal disorders

Most Recent Events

  • 18 Apr 2017 Techfields Pharma plans a phase III trial for Osteoarthritis (NCT03110523)
  • 22 Mar 2017 Techfields Pharma plans a phase III trial for Osteoarthritis (NCT03081806)
  • 08 Jul 2016 Phase-III clinical trials in Fever in World (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top